• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Mining for cancer clues

Bioengineer by Bioengineer
November 13, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: University of Delaware/ Wenbo Fan

Doctors have many weapons in the fight against cancer, but choosing the right one can be a challenge. Soon they will have a new resource to inform them about treatment options.

A group of researchers is building a portal of genetic information to help doctors detect, diagnose and treat cancer optimally in each of their patients. Vijay Shanker, a professor of computer and information sciences at the University of Delaware, is part of the team, which recently received a grant of more than $1.2 million. Shanker will receive $215,737 for his portion of the project.

Cancerous tumors develop when genes go rogue. Sometimes the culprit is a mutation–a fault in a DNA sequence. Sometimes there's a problem with the level of the gene expression, leading to the creation of cancerous tissue. Researchers all over the world have linked mutations and expression patterns of hundreds of biomarkers to cancer incidence, treatment, and prognosis.

This information is held in a variety of databases, including those resulting from the Early Detection Research Network, Cancer Genome Atlas, and International Cancer Genomic Consortium.

The findings have never been collected systematically in one place — but that's about to change.

"We are trying to build on that work further by integrating large-scale experimental results with different kinds of information found in the research literature," said Shanker.

The goal: Someday, oncologists will pull up this data on a tablet and use it to guide treatment decisions.

"For example, this information could be used to predict how mutations might affect drug response, an important aspect of personalized medicine," said Shanker.

This information will also be helpful for clinical researchers developing new medicine.

Shanker is collaborating with researchers at George Washington University, the Swiss Institute of Bioinformatics, and NASA's Jet Propulsion Laboratory.

While this project involves many components, Shanker is in charge of text mining — using research literature to cull important information. Shanker has developed programs to determine which text is relevant, parse that text, and then simplify it and organize it in a useful way. For this project, that means using his software to scour millions of research papers, pull out information about relevant biomarkers and outcomes, and organize them.

Shanker has been doing text mining and natural language processing for nearly three decades. Over the past few years, projects like this one, and another major NIH initiative Shanker is involved in, have taken him in a new direction–health-focused research.

"I've worked mostly on theoretical projects," he said. "Recent research has been more driven by application."

This work could eventually save lives, and that's something Shanker considers often.

"I have really become fascinated by this area and the idea that maybe my research can have an impact on people's health," he said.

###

Media Contact

Peter Bothum
[email protected]
302-831-1418
@UDResearch

http://www.udel.edu

Share12Tweet8Share2ShareShareShare2

Related Posts

PD-1 Inhibitors Enhance Outcomes After CD19 CAR-T

November 9, 2025

Building Inclusive Retirement Home Policies: A Study

November 9, 2025

Desmopressin’s Role in Renal Biopsy Bleeding Outcomes

November 9, 2025

Impact of Perfluoroalkyl Substances on E. coli Phases

November 9, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    315 shares
    Share 126 Tweet 79
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    207 shares
    Share 83 Tweet 52
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    139 shares
    Share 56 Tweet 35
  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1303 shares
    Share 520 Tweet 325

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

PD-1 Inhibitors Enhance Outcomes After CD19 CAR-T

Building Inclusive Retirement Home Policies: A Study

Desmopressin’s Role in Renal Biopsy Bleeding Outcomes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.